Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2018 Mar;46(3):e198-e205.
doi: 10.1097/CCM.0000000000002874.

Thoracic Epidural Analgesia and Mortality in Acute Pancreatitis: A Multicenter Propensity Analysis

Affiliations
Observational Study

Thoracic Epidural Analgesia and Mortality in Acute Pancreatitis: A Multicenter Propensity Analysis

Matthieu Jabaudon et al. Crit Care Med. 2018 Mar.

Abstract

Objective: Recent preclinical and clinical data suggest that thoracic epidural analgesia, a technique primarily aimed at decreasing pain, might exert anti-inflammatory effects, enhance splanchnic and pancreatic blood flow during acute pancreatitis; however, the influence of epidural analgesia on mortality remains under investigated in this setting. This study was therefore designed to assess the impact of epidural analgesia on mortality in ICU patients with acute pancreatitis.

Design: Multicenter retrospective, observational, cohort study.

Setting: Seventeen French and Belgian ICUs.

Patients: All patients admitted to with acute pancreatitis between June 2009 and March 2014.

Interventions: The primary exposure was thoracic epidural analgesia versus standard care without epidural analgesia. The primary outcome was 30-day mortality. Propensity analyses were used to control for bias in treatment assignment and prognostic imbalances.

Measurements and main results: One thousand three ICU patients with acute pancreatitis were enrolled, of whom 212 died within 30 days. Epidural analgesia was used in 46 patients and was associated with reduced mortality in unadjusted analyses (4% vs. 22%; p = 0.003). After adjustment for baseline variables associated with mortality, epidural analgesia was still an independent predictor of 30-day mortality (adjusted odds ratio, 0.10; [95% CI, 0.02-0.49]; p = 0.004). Using propensity score analysis, the risk of all-cause 30-day mortality in patients with acute pancreatitis receiving epidural analgesia was significantly lower than that in matched patients who did not receive epidural analgesia (2% vs. 17%; p = 0.01).

Conclusions: Among critically ill patients with acute pancreatitis, mortality at 30 days was lower in patients who received epidural analgesia than in comparable patients who did not. These findings support ongoing research on the use of epidural analgesia as a therapeutic intervention in acute pancreatitis.

PubMed Disclaimer

Comment in

  • Thoracic Epidural in Pancreatitis.
    Tyagi A, Kumar M. Tyagi A, et al. Crit Care Med. 2018 Jul;46(7):e720-e722. doi: 10.1097/CCM.0000000000003066. Crit Care Med. 2018. PMID: 29912119 No abstract available.
  • The authors reply.
    Jabaudon M, Bulyez S, Constantin JM. Jabaudon M, et al. Crit Care Med. 2018 Jul;46(7):e721-e722. doi: 10.1097/CCM.0000000000003111. Crit Care Med. 2018. PMID: 29912120 No abstract available.

Publication types